Pro-drugs of non-steroidal anti-inflammatory agents.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007213:Indomethacin / Q000031:analogs & derivatives / Q000627:therapeutic use; D010653:Phenylbutazone / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D010654:Phenylbutyrates; D011422:Propionates / Q000627:therapeutic use; D013467:Sulindac / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D010654:Phenylbutyrates; D011422:Propionates; D013467:Sulindac; C026784:acemetacin; C003371:suxibuzone; C010725:fenbufen; D010653:Phenylbutazone; D007213:Indomethacin